New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Large-scale study of nine genes in 4,580 patients with chronic lymphocytic leukemia

Large-scale study of nine genes in 4,580 patients with chronic lymphocytic leukemia

byKarolinska InstitutetCredit: Pixabay/CC0 Public DomainNext-generation sequencing studies have in recent years revealed numerous recurrently mutated genes in chronic lymphocytic leukemia (CLL).
World medicine December 15,2023
Large-scale study of nine genes in 4,580 patients with chronic lymphocytic leukemia

Large-scale study of nine genes in 4,580 patients with chronic lymphocytic leukemia

byKarolinska InstitutetCredit: Pixabay/CC0 Public DomainNext-generation sequencing studies have in recent years revealed numerous recurrently mutated genes in chronic lymphocytic leukemia (CLL).
World medicine December 15,2023
Neighborhood-level factors contribute to liver cancer disparities across Texas

Neighborhood-level factors contribute to liver cancer disparities across Texas

by Molly Chiu,Baylor College of MedicineGraphical abstract. Credit:Clinical Gastroenterology and Hepatology(2022). DOI: 10.1016/j.cgh.2022.06.031Texas has the highest rate of hepatoc
World medicine December 15,2023
Neighborhood-level factors contribute to liver cancer disparities across Texas

Neighborhood-level factors contribute to liver cancer disparities across Texas

by Molly Chiu,Baylor College of MedicineGraphical abstract. Credit:Clinical Gastroenterology and Hepatology(2022). DOI: 10.1016/j.cgh.2022.06.031Texas has the highest rate of hepatoc
World medicine December 15,2023
Cancer deaths due to COVID-19 explored in March to December 2020

Cancer deaths due to COVID-19 explored in March to December 2020

From March to December 2020, more than 16,500 deaths occurred in cancer patients with complications of COVID-19, according to a research letter published online Sept. 29 inJAMA Oncology.Xuesong
World medicine December 15,2023
Cancer deaths due to COVID-19 explored in March to December 2020

Cancer deaths due to COVID-19 explored in March to December 2020

From March to December 2020, more than 16,500 deaths occurred in cancer patients with complications of COVID-19, according to a research letter published online Sept. 29 inJAMA Oncology.Xuesong
World medicine December 15,2023
Laparoscopic surgery noninferior for gastric cancer at five years

Laparoscopic surgery noninferior for gastric cancer at five years

Laparoscopic surgery is noninferior to open gastrectomy for locally advanced gastric cancer (AGC) at five years, according to a study published online July 20 inJAMA Surgery.Sang-Yong Son, M.D.,
World medicine December 15,2023
Laparoscopic surgery noninferior for gastric cancer at five years

Laparoscopic surgery noninferior for gastric cancer at five years

Laparoscopic surgery is noninferior to open gastrectomy for locally advanced gastric cancer (AGC) at five years, according to a study published online July 20 inJAMA Surgery.Sang-Yong Son, M.D.,
World medicine December 15,2023
Resistant starch provides lasting benefit in Lynch syndrome

Resistant starch provides lasting benefit in Lynch syndrome

For patients with Lynch syndrome (LS), daily resistant starch (RS) seems to have a lasting protective effect against noncolorectal cancers, according to a study published online July 25 inCancer
World medicine December 15,2023
Resistant starch provides lasting benefit in Lynch syndrome

Resistant starch provides lasting benefit in Lynch syndrome

For patients with Lynch syndrome (LS), daily resistant starch (RS) seems to have a lasting protective effect against noncolorectal cancers, according to a study published online July 25 inCancer
World medicine December 15,2023
Prior diagnoses influence dermatopathologists' interpretations

Prior diagnoses influence dermatopathologists' interpretations

When interpreting melanocytic skin biopsy specimens, knowledge of a prior diagnosis sways dermatopathologists to make more and less severe diagnoses and can also sway them from a correct to an incorre
World medicine December 15,2023
Prior diagnoses influence dermatopathologists' interpretations

Prior diagnoses influence dermatopathologists' interpretations

When interpreting melanocytic skin biopsy specimens, knowledge of a prior diagnosis sways dermatopathologists to make more and less severe diagnoses and can also sway them from a correct to an incorre
World medicine December 15,2023
Overall survival interim analysis of a Phase III study of atezolizumab vs best supportive care in resected NSCLC

Overall survival interim analysis of a Phase III study of atezolizumab vs best supportive care in resected NSCLC

by International Association for the Study of Lung CancerDr. Enriqueta Felip, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spai. Credit: Dr. Enriqueta Fel
World medicine December 15,2023
Overall survival interim analysis of a Phase III study of atezolizumab vs best supportive care in resected NSCLC

Overall survival interim analysis of a Phase III study of atezolizumab vs best supportive care in resected NSCLC

by International Association for the Study of Lung CancerDr. Enriqueta Felip, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spai. Credit: Dr. Enriqueta Fel
World medicine December 15,2023
New research could lead to a simple blood test for brain tumors

New research could lead to a simple blood test for brain tumors

byUniversity of BristolConcept of how mathematical modeling may be used in the development and deployment of blood-based biomarkers for brain tumors. This figure summarizes the role mathematical
World medicine December 15,2023
New research could lead to a simple blood test for brain tumors

New research could lead to a simple blood test for brain tumors

byUniversity of BristolConcept of how mathematical modeling may be used in the development and deployment of blood-based biomarkers for brain tumors. This figure summarizes the role mathematical
World medicine December 15,2023
Lung cancer risk increased for smokers not offered annual screening

Lung cancer risk increased for smokers not offered annual screening

Smokers for whom annual screening with low-dose computed tomography (LDCT) is not recommended may have a high risk for lung cancer, according to a study published online July 28 inJAMA Oncology.
World medicine December 15,2023
Lung cancer risk increased for smokers not offered annual screening

Lung cancer risk increased for smokers not offered annual screening

Smokers for whom annual screening with low-dose computed tomography (LDCT) is not recommended may have a high risk for lung cancer, according to a study published online July 28 inJAMA Oncology.
World medicine December 15,2023
New drug candidate uses novel absorption method to target cancer cells in mice

New drug candidate uses novel absorption method to target cancer cells in mice

byUniversity of MichiganA model demonstrating how this type of novel drug is absorbed through the lymphatic system. Credit: Danielle Dobbs/Michigan MedicineA team of University of Michigan resea
World medicine December 15,2023
New drug candidate uses novel absorption method to target cancer cells in mice

New drug candidate uses novel absorption method to target cancer cells in mice

byUniversity of MichiganA model demonstrating how this type of novel drug is absorbed through the lymphatic system. Credit: Danielle Dobbs/Michigan MedicineA team of University of Michigan resea
World medicine December 15,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com